BCL2 and B-cell chronic lymphocytic leukemia: Overexpression of anti‐apoptotic BCL2 family members contributes to the development of hematological malignancies including MM,37, 38 CLL,39 acute myeloid leukemia,40 and non‐Hodgkin's lymphoma.41